<i>HLA-DQB1/DQA2</i> lead variant locus in T2D and non-T2D strata. by Margaret Sunitha Selvaraj (13994016)

Subjects:

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals. by Natalie M. Bath (6316517)

“…(A) T (CD3⁺) and (B) B (CD45R⁺) cell flow crossmatch was performed in non-sensitized animals. IgG1⁺ in the T cell flow crossmatch was the only DSA that BLyS^-/- significantly decreased compared to APRIL^-/- (p<0.03). …”

S1 Data - by Mai Ngoc Luu (11868515)

Subjects:

Homozygous microdeletions of SNPs in the rs58923657 non-risk haplotype result in significantly decreased <i>IKZF1</i> expression and increased proliferation in human LCLs. by Vincent U. Gant (9955199)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Subjects:

Characteristics of non-septic (qSOFA = 0) and septic (qSOFA≥1) emergency unit patients with suspected infections (N = 17,490). by Brian Rice (4393609)

Significant compounds based on significant Analysis of Metabolites of <i>S. shimperi</i> extracts by METLIN on XCMS. by M. Azene (22553313)

“…<p>Significant compounds based on significant Analysis of Metabolites of <i>S. shimperi</i> extracts by METLIN on XCMS.…”

CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Subgroup analysis of BUN based on pump type. by Mohamed R. Abdelraouf (21501468)

“…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”

Subgroup analysis of BUN based on surgery type. by Mohamed R. Abdelraouf (21501468)

“…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”

Cooperative populations have a rescue probability comparable to that of non-cooperative ones only when their growth rate is significantly higher. by Yaron Goldberg (10164674)

Risk of bias assessment in the non-RCTs of Wang, 2013 –ROBINS-I tool. by Luz Estella Mesa (8339283)

Subgroup analysis of ICU Stay based on pump type. by Mohamed R. Abdelraouf (21501468)

“…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”

Subgroup analysis of eGFR based on pump type. by Mohamed R. Abdelraouf (21501468)

“…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”

Downstream functional effect prediction of pathogenic SNPs based on various <i>in-silico</i> tools. by Muhammad Bilal Azmi (14519913)

Subjects:

Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss. by Thomas R. Shearer (9761486)

Adjusted means and 95% confidence interval of blood pressure change from baseline to the follow-up in different general or abdominal obesity status change groups. by Yi-de Yang (6755798)

Subjects:

Distribution of rare nsSNPs based on transcript sequences. by Muhammad Bilal Azmi (14519913)

Subjects:

Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression... by Lucy Granat (5570813)